ROSEN, LEADING INVESTOR COUNSEL, Encourages Western Alliance Bancorporation Investors to Inquire About Securities Class Action Investigation – WAL

New York, New York–(Newsfile Corp. – November 25, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public. SO […]

Readout – Prime Minister Carney participates in a virtual meeting in support of Ukraine

Today, the Prime Minister, Mark Carney, participated in a virtual meeting of the Coalition of the Willing in support of Ukraine. The meeting was co-chaired by the President of France, Emmanuel Macron, the Prime Minister of the United Kingdom, SirKeir Starmer, and the Chancellor of Germany, Friedrich Merz. The President of Ukraine, Volodymyr Zelenskyy, and

Footprints Floors Launches First Annual First Fruits Service Day to Strengthen Families and Local Communities

Footprints Floors, a national leader in residential flooring services, proudly announces the launch of its First Annual First Fruits Service Day on Wednesday, November 26, 2025, a new corporate initiative dedicated to serving family-focused organizations and community programs across the country. https://mma.prnewswire.com/media/2832177/Footprints_Floors_logo.jpg First Fruits is the charitable arm of Footprints Floors and reflects the company's

IC Group Holdings Inc. Announces 74 Percent Revenue Growth in Third Quarter 2025

Toronto, Ontario–(Newsfile Corp. – November 25, 2025) – IC Group Holdings Inc. (TSXV: ICGH) (“IC Group” or the “Company”), a technology-enabled consumer engagement company that helps global brands drive commerce with consumers, today announced its unaudited financial results for the three and nine months ended September 30, 2025. All figures are reported in Canadian dollars unless otherwise

FCX INVESTOR NOTICE: Freeport McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

San Diego, California–(Newsfile Corp. – November 25, 2025) – Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Freeport-McMoRan Inc. (NYSE: FCX) publicly traded securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”), have until January 12, 2026 to seek appointment as lead plaintiff of the Freeport-McMoRan class

The Poirier Group Responds to Ontario Government Directive for Hospital Cost Savings, Advocates Systemic Operational Reform Over Service Cuts

Toronto, Ontario–(Newsfile Corp. – November 25, 2025) – The Poirier Group (TPG), a management consulting firm specializing in healthcare and operational excellence, has issued a statement responding to the Ontario government’s recent directive instructing hospitals to identify cost savings within their operations. According to TPG’s Healthcare Partner, Dale Schattenkirk, the directive presents both a challenge

Elme Communities Declares Initial Special Liquidating Distribution

(NYSE:ELME), BETHESDA, Md., Nov. 25, 2025 (GLOBE NEWSWIRE) — Elme Communities (“Elme” or the “Company”) (NYSE: ELME) today announced that its Board of Trustees has approved a special liquidating distribution of $14.67 per share (the “Special Dividend”). The Special Dividend will be paid on January 7, 2026 to shareholders of record at the close of

Elme Communities Declares Initial Special Liquidating Distribution

Elme Communities Declares Initial Special Liquidating Distribution GlobeNewswire November 25, 2025 BETHESDA, Md., Nov. 25, 2025 (GLOBE NEWSWIRE) — Elme Communities (“Elme” or the “Company”) (NYSE: ELME) today announced that its Board of Trustees has approved a special liquidating distribution of $14.67 per share (the “Special Dividend”). The Special Dividend will be paid on January

Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5% During the Forecast Period (2025-2034) Driven by Recent Approvals and Pipeline Advancements and Rising Awareness | DelveInsight

The mitochondrial myopathies treatment market is expected to grow steadily, driven by the recent approval of FORZINITY and KYGEVVI, improved diagnosis, and rising awareness. Additionally, the expected launch of therapies such as Sonlicromanol (Khondrion; redox modulator), KL1333 (Pharming; NAD?/NADH modulation), Zagociguat (Tisento/Cyclerion; sGC stimulation), TTI-0102 (Thiogenesis; thiol-based mitochondrial support), and others will also propel the

Scroll to Top